{"slideshow_credits": null, "snippet": "Epidiolex, in its first major clinical trial, reduced convulsive seizures in young patients with Dravet syndrome, according to GW Pharmaceuticals.", "abstract": "GW Pharmaceuticals says its experimental drug Epidiolex, which is derived from marijuana, succeeds in lessening epileptic seizures in its first major medical trial; if approved by regulators, Epidiolex would be first prescription drug in United States extracted from marijuana.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2016/03/15/business/marijuana-based-drug-found-to-reduce-epileptic-seizures.html", "lead_paragraph": "Epidiolex, in its first major clinical trial, reduced convulsive seizures in young patients with Dravet syndrome, according to GW Pharmaceuticals.", "headline": {"main": "Marijuana-Based Drug Found to Reduce Epileptic Seizures", "print_headline": "Drug Based on Cannabis Meets Goal of Big Trial"}, "_id": "56e6cc1c38f0d82d8fe3a16a", "word_count": "1038", "multimedia": [{"height": 126, "url": "images/2016/03/15/business/15drug2/15drug2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/03/15/business/15drug2/15drug2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 393, "url": "images/2016/03/15/business/15drug2/15drug2-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/15/business/15drug2/15drug2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "393"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/03/15/business/15drug2/15drug2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/15/business/15drug2/15drug2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-03-15T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "GW Pharmaceuticals PLC.", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Medical Marijuana", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Epilepsy", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "4"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "N", "rank": "5"}, {"name": "glocations", "value": "Colorado", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Marijuana", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}